Skip to content

Ethanol lock therapy for catheter related blood stream infection in pediatric patients with a tunneled catheter or a vascular access port

Ethanol lock therapy for catheter related blood stream infection in pediatric patients with a tunneled catheter or a vascular access port - Ethanol lock therapy for catheter related blood stream infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028571
Enrollment
20
Registered
2017-08-15
Start date
2017-09-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter related blood stream infection in patients with a tunnelled catheter

Interventions

Ethanol rock therapy

Sponsors

Keio university hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a tunneled catheter(silicone) or a port fulfilling below requirements A 1. Diagnosed as a CRBSI by positive blood culture obtained through the catheter along with negative blood culture via peripheral blood 2. No other source of infection B The sample obtained through the catheter becomes positive in blood culture 2 hours < faster than the one obtained from peripheral blood. Informed consent must be obtained.

Exclusion criteria

Exclusion criteria: 1. patients with a non-silicone catheter 2. allergic to ethanol 3. any other conditions that doctors in charge think inappropriate for the treatment

Design outcomes

Primary

MeasureTime frame
1. The salvage rate of the catheter 2. The response rate (the rate of negative blood culture obtained on day 5) 3. The rate of recurrent fever which is supposed to be due to catheter related blood stream infection 4. The recurrent rate of CRBSI within 4weeks after the ethanol rock therapy 5. adverse event

Countries

Japan

Contacts

Public ContactKiyotomo Abe

Keio University Hospital Department of Pediatric Surgery

kiyotomo@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026